documents: FDA-2015-N-3326-0056

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2015-N-3326-0056 FDA FDA-2015-N-3326 Reauthorization of the Biosimilar User Fee Act; Public Meeting; Request for Comments Notice Request for Comments 2026-09-25T04:00:00Z 2026 9 2026-09-25T04:00:00Z 2026-11-26T04:59:59Z 2026-10-06T09:00:35Z 2026-19660 1 0 09000064b95c53b7

Links from other tables